Taking 0.15 mg of nonivamide every day for 12 weeks does not change the patterns of metabolites in the blood or the types of bacteria in the gut of moderately overweight adults.
Mechanism
Synthesis from 1 study
A tiny daily dose of nonivamide for 12 weeks activates a gut sensor called TRPV1, which makes intestinal cells release more serotonin into the blood (10.1002/mnfr.201600731). This helps reduce fat gain, but it doesn’t change the chemicals in your blood or the bacteria in your gut — so those aren’t...
Most probable mechanism
Taking a tiny daily dose of nonivamide for 12 weeks activates a specific sensor in the gut called TRPV1, which causes cells in the intestine to release more serotonin into the blood (10.1002/mnfr.201600731). This increase in serotonin may help reduce fat gain, but it doesn’t change the mix of chemicals in the blood or the types of bacteria in the gut — meaning those pathways aren’t how nonivamide works.
Nonivamide binds to and activates TRPV1 receptors on enterochromaffin cells in the intestinal epithelium (10.1002/mnfr.201600731)
TRPV1 activation induces calcium influx into enterochromaffin cells (10.1002/mnfr.201600731)
Calcium influx triggers exocytosis of serotonin-containing vesicles from enterochromaffin cells (10.1002/mnfr.201600731)
Released serotonin enters systemic circulation, elevating plasma serotonin concentrations (10.1002/mnfr.201600731)
Daily administration of 0.15 mg nonivamide for 12 weeks does not alter plasma metabolome profiles or fecal microbiota composition in moderately overweight adults (10.1002/mnfr.201600731)
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.